Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Apyx Medical Corp Director's Dealing 2014

Oct 16, 2014

34303_dirs_2014-10-16_0a822c3b-e2a0-4988-8eda-b84d3d261b0b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: BOVIE MEDICAL CORP (BVX)
CIK: 0000719135
Period of Report: 2014-03-31

Reporting Person: McCarthy John J. III (Chief Commercialization Officr)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (option to buy) $3.61 2024-03-31 Common Stock (213000) Direct

Footnotes

F1: Reporting person was granted a stock option to vest and be exercisable over 4 years at the rate of 25% of the option on the anniversary date of each succeeding year and shall become fully vested and fully exercisable on the fourth anniversary of the date of grant.